Sandostatin
Brand Name: Sandostatin
Generic Name: Octreotide (As Acetate)
Active
Registration Number
DR-XY18025
Dosage Form
Solution For S.C. Injection / I.V. Infusion
Issuance Date
August 31, 2022
Expiry Date
August 31, 2027
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength500 mcg/mL
Packaging1 mL USP Type I clear & colorless glass ampule (Box of 5's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Somatostatin Analogue
A
Application
Initial (Variation)
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Octreotide (As Acetate)Active
Monograph: Octreotide